Estimating the costs of drug-related hospital separations in Australia

Australian and New Zealand Journal of Public Health
Steven RiddellAmanda Roxburgh

Abstract

To estimate the total hospital costs of drug-related separations in Australia from 1999/2000 to 2004/05, and separate costs for the following illicit drug classes: opioids, amphetamine, cannabis and cocaine. Australian hospital separations between 1999/2000 to 2004/05 from the National Hospital Morbidity Dataset (NHMD) with a principal diagnosis of opioids, amphetamine, cannabis or cocaine were included, as were indirect estimates of additional 'drug-caused' separations using aetiological fractions. The costs were estimated using the year-specific case weights and costs for each respective Diagnostic Related Group (DRG). Total constant costs decreased from $50.8 million in 1999/2000 to $43.8 million in 2002/03 then increased to $46.7 million in 2004/05. The initial decrease was driven by a decline in numbers of opioid-related separations (with costs decreasing by $11.5 million) between 1999/2000 and 2001/02. Decreases were evident in separations within the opioid use, dependence and poisoning DRGs. Increases in costs were observed between 1999/00 and 2004/05 for amphetamine (an increase of $2.4 million), cannabis ($1.8 million) and cocaine ($330,000) related separations. Several uncommon but very expensive drug-related separati...Continue Reading

References

Jan 1, 1995·American Journal of Public Health·K FoxJ A Califano
Dec 10, 1990·Journal of Health & Social Policy·M T FrenchR L Hubbard
Aug 29, 2002·Archives of Pediatrics & Adolescent Medicine·Flaura K WinstonTed R Miller
Nov 5, 2002·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Christina M MitchellUNKNOWN Pathways of Choice and Healthy Ways Project Team
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·D F PensonP R Carroll
Feb 5, 2003·European Addiction Research·Philippe FenoglioPierre Kopp
Apr 16, 2003·Heart·Rob Moss, Brad Munt
Jun 7, 2003·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Shane Darke, Wayne Hall
Nov 2, 2004·Journal of Analytical Toxicology·Fiona J CouperBarry K Logan
Mar 15, 2005·Drug and Alcohol Review·David J KavanaghMaree Teesson
Mar 24, 2005·Addiction·Louisa DegenhardtWayne Hall
Nov 22, 2005·Drug and Alcohol Review·Rebecca McKetinDevon Indig
Dec 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Mikkel ArendtPovl Munk-Jørgensen
May 16, 2006·Addiction·Lucy BurnsMargaret Cooke
May 23, 2006·Psychiatry Research·Jitender SareenMurray B Stein
Nov 30, 2006·Psychology, Health & Medicine·UNKNOWN The National Institute Of Mental Health Multisite HIV Prevention Trial Group
Feb 3, 2007·International Journal of Methods in Psychiatric Research·Jürgen RehmGerhard Gmel
Apr 5, 2007·The Medical Journal of Australia·Louisa DegenhardtRebecca McKetin
Nov 21, 2007·Bulletin of the World Health Organization·Travis J RiddellJohn W Peabody

❮ Previous
Next ❯

Citations

May 27, 2014·Issues in Mental Health Nursing·Warren HarlowGraeme Browne Rn
Dec 1, 2012·Drug and Alcohol Review·M Mofizul IslamCarolyn A Day
Sep 13, 2015·Drug and Alcohol Dependence·Stephen J KaarDan I Lubman
Aug 20, 2019·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Anne-Marie DescampsDominique Vandijck
Aug 6, 2021·Cost Effectiveness and Resource Allocation : C/E·Jon Hjellum VibetoKnut Reidar Wangen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.